Intersect ENT (XENT) Misses Q1 EPS by 10c, Revenues Miss

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/5/2026

1. AMD
2. BKNG
3. DOX
4. AMGN
5. DUOL
6. ANET
7. SWKS
8. CVS
9. SPY
10. XYZ

Go back to Intersect ENT (XENT) Misses Q1 EPS by 10c, Revenues Miss

Intersect ENT Reports First Quarter 2020 Results

May 11, 2020 7:01 AM EDT

MENLO PARK, Calif.--(BUSINESS WIRE)-- Intersect ENT, Inc. (Nasdaq: XENT), a company transforming care for patients with ear, nose and throat (ENT) conditions, today reported financial results for the first quarter ended March 31, 2020.

First Quarter 2020 Overview

Revenue of $19.8 million in the first quarter of 2020, compared to $26.7 million in the first quarter of 2019 Cash, Cash Equivalents and Short-term Investments of $87.7 million as of March 31, 2020, compared to $90.6 million as of December 31, 2019.

Total revenue was $19.8 million for the first quarter of 2020 compared to $26.7 million for the same... More